Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Healthcare Bull 3X ETF

121.88
-0.9600-0.78%
Post-market: 121.880.00000.00%19:31 EDT
Volume:38.84K
Turnover:4.77M
Market Cap:164.54M
PE:- -
High:125.60
Open:125.15
Low:121.56
Close:122.84
52wk High:150.00
52wk Low:74.34
Shares:1.35M
Float Shares:1.35M
Volume Ratio:0.67
T/O Rate:2.88%
Dividend:1.25
Dividend Rate:1.03%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
3 hours ago

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
19 hours ago

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Yesterday

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Yesterday

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Yesterday

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Yesterday

Growth Without AI: 8 Stock Picks

Dow Jones
·
Yesterday

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Yesterday

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Reuters
·
Sep 09

Structure weakness ‘disconnected’ from underlying data, says Jefferies

TIPRANKS
·
Sep 09

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

TIPRANKS
·
Sep 09

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

TIPRANKS
·
Sep 08

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Reuters
·
Sep 08

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Stock News
·
Sep 07

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Reuters
·
Sep 07

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Reuters
·
Sep 07

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

TIPRANKS
·
Sep 05